FREMONT, Calif. , Feb. 23, 2017 /PRNewswire/ -- Velos, Inc. recently launched a new webinar series as a part of its mission to promote innovative and more efficient clinical research management. The complimentary webinar series features insights from subject matter experts and thought leaders ...
Read MoreNEW YORK , February 23, 2017 /PRNewswire/ -- This morning, Stock-Callers.com dedicates its attention to these Healthcare stocks: Valeant Pharmaceuticals International Inc. (NYSE: VRX), CVS Health Corp. (NYSE: CVS), Express Scripts Holding Co. (NASDAQ: ESRX), and UnitedHealth Group Inc. (NYSE: ...
Read MorePUNE, India , February 23, 2017 /PRNewswire/ -- According to a new market research report " Influenza Diagnostics Market Test type (Traditional (Rapid Influenza Detection Test, Viral Culture, DFA, Serology Test), Molecular (RT-PCR, NASBA, LAMP, SAMBA)), End user (Hospital, Clinic, Reference ...
Read MoreNew Shortlister research reveals the trends that well-being experts believe will define the corporate wellness industry in the coming years. CHICAGO , Feb. 23, 2017 /PRNewswire/ -- Shortlister , the leading authority in sourcing human capital and wellness providers, released new research ...
Read MoreCompany orders, and pays for, 6 initial 'Quick Deploy Systems' and commits to future orders for "SMART by Design™" models built by Zerez Holdings' subsidiary Next Generation Farming, Inc. SACRAMENTO, Calif. , Feb. 23, 2017 /PRNewswire/ -- Zerez Holdings Corporation (OTC PINK: ZRZH) ...
Read MoreLONDON , February 23, 2017 /PRNewswire/ -- PharmaBoardroom today releases its new 58-page Healthcare & Life Sciences Review Singapore 2017. This report offers companies, investors, policymakers, and stakeholders crucial insight into Singapore ; a nation that has had to carve out its ...
Read MoreJACKSONVILLE, Fla. , Feb. 23, 2017 /PRNewswire/ -- Nationally renowned eating disorder expert Lori Osachy , MSS, LCSW is launching a first-of-its-kind mental health program on Feb. 26 . Powered by CareWire, Inc. ( www.carewireinc.com ), the text2Bwell Positive Body Image Program ( ...
Read MoreSEATTLE , Feb. 23, 2017 /PRNewswire/ -- A colorful event brightened a long-term care convention on January 14 at the Sheraton Seattle Hotel. Over 100 participants wore purple capes as "wizards" to help "kill the wicked witch of Alzheimer's," the mind-robbing disease that afflicts millions. ...
Read MoreThe Bredesen Protocol™'s ReCODE™ supersedes MEND, in its advanced prevention and reversal of cognitive decline SAN FRANCISCO , Feb. 23, 2017 /PRNewswire/ -- The inventor and developer of the original MEND protocol ( m etabolic e nhancement for n euro d egeneration), Dr. Dale Bredesen , ...
Read MoreNEW YORK , Feb. 23, 2017 /PRNewswire/ -- The global diabetic food market is expected to reach USD 11.76 billion by 2025, according to a new report by Grand View Research, Inc. Rising demand for diabetic food in the medical sector is anticipated to fuel the market growth. Rising health ...
Read MoreNEW YORK , Feb. 23, 2017 /PRNewswire/ -- The Clustered regularly interspaced short palindromic repeats CRISPR and CRISPR-associated (Cas) genes market is anticipated to reach USD 4.09 billion by 2025, according to a new report by Grand View Research, Inc. This genome editing principle spans ...
Read MoreNEW YORK , Feb. 23, 2017 /PRNewswire/ -- The global predictive genetic testing & consumer/wellness genomics market is anticipated to reach USD 4.6 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers attributing to the market expansion include: rising ...
Read MoreKOLKATA , February 23, 2017 /PRNewswire/ -- DATRI, India's largest adult unrelated Blood Stem Cell Donors Registry, today organized a very special event to celebrate blood stem cell donor Sajat Jain. Sajat, a 27-year-old, not just saved the life of Nilesh Kumar Sinha , a 42-year-old ...
Read MoreCAMBRIDGE, Massachusetts , February 23, 2017 /PRNewswire/ -- Results Served as Basis for Ongoing P hase 3 Trial Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare diseases, today announced the publication of results from the Phase 1b study of lanadelumab ( SHP643 ; formerly ...
Read MoreSubscribe to our Free Newsletters!